Clinical trials recruiting for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
4
Recruiting trials
0
US states with sites
3
Countries
50%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CT103A cells | 1 |
| Cyclophosphamide and fludarabine | 1 |
Self-screener
Recruiting trials
- Cohort Study on Neuroimmune Diseases in the Reproductive Age
- Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Related conditions
Trials recruiting for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) often also study these conditions. Each links to its own recruiting-trial list.
Multiple sclerosis 445Neuromyelitis Optica Spectrum Disorder 5Myasthenia Gravis 10Autoimmune Encephalitis 6Temporal Lobe Epilepsy 4Parkinson's disease 522Optic Neuritis 6Neuromyelitis Optica Spectrum Disorders 5Mild Traumatic Brain Injury 5Lupus 332
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.